Figure 2.
Effects of myricetin on the plasma corticosterone levels of mice subjected to repeated restraint stress for 21 consecutive days. Myricetin treatment reversed the increase in the plasma corticosterone of the mice subjected to repeated restraint stress. Regular two-way ANOVA, drug(myricetin) × treatment(stress) interaction F(1,24) = 8.68, p < 0.01; significant treatment variation F(1,24) = 353.07, p < 0.001; significant drug variation F(1,24) = 28.17, p < 0.001, Boferroni post-test, *** p < 0.001 significant difference between groups.